FDA approves new HIV drug from J&J

The FDA approved Johnson & Johnson's HIV drug Prezista for treating patients who do not respond to treatment with other antiretroviral medicines. Prezista is in the class of protease inhibitor drugs, which work by blocking protease, a protein HIV needs to copy itself.

View Full Article in:

Newsday (Long Island, N.Y.) (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC